Weakness in Intuitive Surgical (ISRG) is A Buying Opportunity - Goldman Sachs
- Wall Street closes higher as investors digest earnings, megacap outlook
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
Barrington Research Adds Intuitive Surgical (ISRG) to 'Best Ideas List'
April 19, 2013 1:11 PM EDTEarlier, Barrington Research reiterated its Outperform rating on Intuitive Surgical (NASDAQ: ISRG) and added the stock to its 'Best Ideas List' following Q1 results after the close. The price target of $650 was also maintained.
"We view ISRG as best in-breed and liquid enough that everyone can invest... More
Intuitive Surgical (ISRG) Sees Procedure Growth at Low End of 20-23% Range
April 18, 2013 5:07 PM EDTIntuitive Surgical, Inc. (NASDAQ: ISRG) says procedure growth will be at lower end of 20-23%. Revenues growth at higher end of prior 16-19% view.... More
Intuitive Surgical, Inc. (ISRG) Tops Q1 EPS by 56c, Sales Rise 23%
April 18, 2013 4:06 PM EDT(Updated - April 18, 2013 4:37 PM EDT)
Intuitive Surgical, Inc. (NASDAQ: ISRG) reported Q1 EPS of $4.56, $0.56 better than the analyst estimate of $4.00. Revenue for the quarter rose 23% to $611 million versus the consensus estimate of $583.59 million.
"We are pleased with our first quarter revenue and earnings growth. Despite a concerted effort by vocal... More